Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 12:34 ET | Source: Lucent Vision - Fountain Valley

Lucent Vision Offers SMILE Eye Surgery in Fountain Valley and Huntington Beach, California

Fountain Valley, California, March 24, 2026 (GLOBE NEWSWIRE) -- Fountain Valley, California - March 24, 2026 - - Lucent Vision is a boutique ophthalmology practice led by fellowship-trained...
March 24, 2026 09:00 ET | Source: BioAge Labs, Inc.

BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025

Positive interim Phase 1 data for BGE-102, a potent, structurally novel, orally available, brain-penetrant small-molecule NLRP3 inhibitor, demonstrating potential best-in-class reductions in...
March 24, 2026 07:45 ET | Source: Ocugen

Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at 12 months (p< 0.05)Potential 2X treatment benefit compared to 15% and 22%...
March 23, 2026 19:05 ET | Source: Curative Biotechnology, Inc. 

Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting

Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBTD) (“Curative” or the...
March 23, 2026 16:05 ET | Source: Surrozen, Inc.

Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
March 23, 2026 12:22 ET | Source: Research and Markets

U.S. AI-driven Diabetic Retinopathy Screening Market Trends 2026-2033 Featuring Profiles of Eyenuk, Digital Diagnostics, AEYE Health, Optomed, IRIS and Other Key Players

Dublin, March 23, 2026 (GLOBE NEWSWIRE) -- The "U.S. AI-driven Diabetic Retinopathy Screening Market Size, Share & Trends Analysis Report by Component, Screening, Deployment Mode, End Use, and...
March 23, 2026 11:00 ET | Source: F. Hoffmann-La Roche Ltd

Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development

The new building is part of a CHF 1.4 billion site investment, reinforcing Roche’s commitment to Switzerland and the Basel life sciences clusterThe Institute of Human Biology (IHB) enables scientists...
March 23, 2026 08:30 ET | Source: CDT Equity Inc.

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
March 23, 2026 07:02 ET | Source: Ocugen

Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic Atrophy

MALVERN, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...
March 23, 2026 07:00 ET | Source: Curative Biotechnology, Inc. 

Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting

Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative” or the...